Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gamma Biologicals was a medical diagnostic company specializing in the development, manufacture, and sale of reagents and controls used in blood group serology. Based in Houston, Texas, the company provided essential products for blood banks and clinical laboratories to ensure safe blood transfusions. Its product line included blood grouping sera, reagent red blood cells, and anti-human globulin, which are critical for identifying blood types and detecting antibodies. The company was a pioneer in utilizing monoclonal antibody technology for blood typing applications, improving the specificity and reliability of tests. In 1998, Gamma Biologicals was acquired by Immucor, a leader in transfusion medicine, for approximately $26 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gamma Biologicals.